Let's get to Eli Liy here. Surging almost 4% today after a beat and raise uh earnings report thanks to booming demand for its GLP1 drugs zbound in Monjaro. Also an obese obesity Novo Nordisk down 2 and a half% after confirming that it has made an unsolicited bid to acquire Meter better than the offer that Fizer had made last month.Semaphore reporting this afternoon that Fizer is considering a lawsuit against Novo and Metsa over the bid. For more on all of this, Missouo healthcare strategist Jared Holles is ...